TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center in El Paso, take a look at the leading medical stories of the week.
Today’s subjects consist of Medicare settlement on drug rate contrast, messaging to enhance adherence to heart disease (CVD) medications, maternal cancer detection, and energetic periodic way of life exercise (VILPA).
Program notes:
1:02 Incidental detection of maternal cancer
2:02 Have irregular blood tests
3:04 Call into concern what to do with the findings
3:50 Text messaging to enhance adherence to CVD medications
4:51 Get generic tips
5:50 Wide age variety and conditions
6:50 Does aid in some situations
7:26 Physical activity and cardiovascular occasions
8:26 Vigorous periodic way of life activity or VILPA
9:30 U.K. Biobank population
10:30 At least some short periodic activity
10:44 United States drug costs under Medicare settlement compared to peers
11:43 8% to 42% compared to before settlement
12:43 Net costs decreased 22%
13:23 End
Records:
Elizabeth: How do drug costs worked out by Medicare compare to other peer nations?
Rick: Does short, however energetic exercise enhance results?
Elizabeth: Can we utilize customized client information and behavioral pushes to get individuals to take their cardiovascular medications?
Rick: And incidental detection of maternal cancer.
Elizabeth: That’s what we’re speaking about today on TTHealthWatch, your weekly take a look at the medical headings from Texas Tech University Health Sciences Center in El Paso. I’m Elizabeth Tracey, a Baltimore-based medical reporter.
Rick: And I’m Rick Lange, president of Texas Tech University Health Sciences Center in El Paso, where I’m likewise dean of the Paul L. Foster School of Medicine. Before we start, we simply closed the Thanksgiving vacation and I simply wish to appreciate for the truth that we’re now entering our 20th year of podcasting together. Thank you quite, Elizabeth.
Elizabeth: Thank you quite, Rick. Any listener who wishes to weigh in on that, we would deeply value it. Thanks to all of you who likewise listen to us. On that note, which of these would you like to begin with?
Rick: The incidental detection of maternal cancer.
This is a post in the New England Journal of MedicineBlood is consistently attracted pregnant ladies searching for what’s called fetal aneuploidy, proof that the fetus has irregular chromosome numbers. Many DNA is included in cells, however this is searching for cell-free– that is, flowing– DNA, which roughly 10% originates from the placenta and about 90% originates from the blood system of the pregnant individual.
Usage of this blood test has actually changed intrusive diagnostic treatments such as amniocentesis,
